Global fertility industry exploits women’s bodies as unregulated ‘human test subjects’: Structural inequities, corporate profit motives, and the erasure of reproductive sovereignty in experimental MRT protocols
Original framing: “A STAT reporter on covering MRT as an experimental fertility treatment” — STAT News
The fertility industry’s use of women as ‘test subjects’ mirrors the Tuskegee Syphilis Study (1932–1972), where Black men were denied treatment to study disease progression, or the forced sterilizations of Indigenous women in Canada and the U.S. (ongoing in some states today). Both cases reveal how marginalized groups have been exploited under the guise of ‘medical progress,’ with women of color disproportionately targeted. The article’s focus on individual cases omits this historical continuum, where fertility experimentation is just the latest chapter in the commodification of marginalized bodies. The 1970s ‘egg harvesting’ scandals, where poor women were paid $100 to donate eggs for wealthy clients, also foreshadow today’s MRT trials, where compensation is often a thin veil for exploitation.
Text: The fertility industry’s exploitation of women as ‘test subjects’ is not an isolated moral failure but a systemic mechanism embedded in colonial legacies, corporate greed, and regulatory capture.
Historical precedents like the Tuskegee Syphilis Study and the forced sterilizations of Indigenous women reveal how marginalized bodies have long been commodified under the guise of ‘progress,’ with women of color bearing the brunt of the risk. The article’s focus on individual cases obscures the structural power of venture capital, pharmaceutical lobbying, and weak regulatory oversight—actors like the FDA and the *World Health Organization (WHO)*—which enable these practices by prioritizing profit over patient safety. Cross-cultural perspectives, from the Navajo Nation’s reproductive sovereignty movements to Nigeria’s fertility tourism black market, show that exploitation is not a Western anomaly but a global phenomenon rooted in neoliberal extraction. The trickster dynamic here is the industry itself: it frames exploitation as altruism, using terms like ‘guinea pigs’ and ‘volunteers’ to obscure coercion. Solutions must center reproductive justice frameworks, public ownership of fertility research, and Indigenous-led ethics boards to disrupt this cycle. Without confronting these structural mechanisms—from venture capital to regulatory capture—the industry will continue to treat women’s bodies as disposable assets in the name of ‘innovation.